Loading...
Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases
BACKGROUND: Polypharmacy is associated with dyspnea in cross-sectional studies, but associations have not been determined in longitudinal analyses. Statins are commonly prescribed but their contribution to dyspnea is unknown. We determined whether polypharmacy was associated with dyspnea trajectory...
Na minha lista:
| Udgivet i: | Am J Hosp Palliat Care |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318598/ https://ncbi.nlm.nih.gov/pubmed/31550901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1049909119877512 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|